ROBRINA WALKER PHD Curriculum vitae W… · Research Update in the Addictions University of Texas Southwestern Medical Center, Dallas, TX 2013 Conference Co-Director, Texas Addiction

R. Walker (standardized UT Southwestern CV template) 1

ROBRINA WALKER, PHD Curriculum vitae

Date Prepared: 6.28.2019

Name: Robrina Walker, PhD

Office Address:

5323 Harry Hines Boulevard Dallas, TX 75390-9119

Work Phone: 214.645.6980

Work E-Mail: [email protected]

Work Fax: 214.648.0167

Place of Birth: United States

Education

Year Degree Field of Study Institution

1999 BS, magna cum laude

Psychology Minor: Sociology

Appalachian State University, Boone, NC

2002 MS Clinical Psychology Virginia Tech, Blacksburg, VA

2005 Chief Resident Predoctoral Internship, Clinical Psychology

University of Mississippi Medical Center / G.V. (Sonny) Montgomery VAMC Consortium, Jackson, MS

2007 PhD Clinical Psychology (Dissertation Chair: Robert S. Stephens, Ph.D.)

Virginia Tech, Blacksburg, VA

Postdoctoral Training [Include residency/fellowship]

Year(s) Titles Specialty/Discipline Institution

2007 – 2008 Fellow Interdisciplinary Postdoctoral Fellowship in Clinical Psychology, emphasis in substance abuse

Dallas Division of the North Texas Veterans Health Care System, Dallas, TX

Faculty Academic Appointments

Year(s) Academic Title Department Academic Institution

2008 – 2016 Assistant Professor Psychiatry University of Texas Southwestern Medical Center, Dallas, TX

mailto:[email protected]


2016 – present

Associate Professor Psychiatry University of Texas Southwestern Medical Center, Dallas, TX

Current Licensure and Certification Licensure Licensed Psychologist, State of Texas (2009 - present) Board and Other Certification Certified Trainer for the National Institute on Drug Abuse (NIDA) / Substance Abuse and Mental Health Services Administration (SAMHSA) Blending Initiative – Promoting Awareness of Motivational Incentives. Certified Trainer for the National Institute on Drug Abuse (NIDA) / Substance Abuse and Mental Health Services Administration (SAMHSA) Blending Initiative – Buprenorphine Treatment: Training for Multidisciplinary Addiction Professionals. Honors and Awards

Year Name of Honor/Award Awarding Organization

1996 – 1999 Academic Scholarship Appalachian State University

1997 Gamma Beta Phi Society Appalachian State University

1998 Alpha Chi National Honor Society Appalachian State University

2002 Graduate Student Assembly Travel Fund

Virginia Tech

2004 – 2005 Chief Resident University of Mississippi Medical Center / G.V. (Sonny) Montgomery VAMC Consortium

2009 NIDA Early Career Investigator Travel Award

National Institute on Drug Abuse (NIDA)

Appointments at Hospitals/Affiliated Institutions

Past

none

Current

Year(s) Position Title Department/Division Institution

2015 – 2022 Member, Graduate School Faculty

Clinical Psychology Graduate Program

University of Texas Southwestern Medical Center, Dallas, TX


Other Professional Positions [Industry, foundation, private practice] none Major Administrative/Leadership Positions [Do not include Professional Society positions]

Year(s) Position Title Institution

2008 – present

Scientific Director, Texas Node of the National Institute on Drug Abuse’s National Drug Abuse Clinical Trials Network


2009 – present

Node Coordinator, Texas Node of the National Institute on Drug Abuse’s National Drug Abuse Clinical Trials Network


2010 - 2014 National Training Director, CTN-0037 Stimulant Reduction Intervention using Dosed Exercise (STRIDE)


2012 - 2014 National Project Director, CTN-0048-A-1 Cocaine Use Reduction with Buprenorphine Genetics Sub-study


2014 – 2015 Clinical Psychology Pre-doctoral Practicum Director, Mood Disorders Research Program and Clinic


2015 – present

Co-Lead Investigator and National Project Director, CTN-0068 Accelerated Development of Additive Pharmacotherapy for Methamphetamine Use Disorder (ADAPT-2)


Committee Service (Member, unless noted otherwise) [Do not include Professional Society positions]

Year(s) Name of Committee Institution/Organization

UTSW

2014 – present Research Committee, Psychology Division University of Texas Southwestern Medical Center, Clinical Psychology Graduate Program, Dallas, TX

2018 - present Faculty Advisor to junior faculty. 2018: one advisee. 2019: two.

University of Texas Southwestern Medical Center, Psychiatry Career Advising Program

2019 - present Callier Child Care Advisory Team University of Texas Southwestern Medical Center, Callier Child Development Center


Hospital

none

State/Regional

2012 Conference Co-Director, Texas Addiction Research to Practice Conference: Learn How Science Can Improve Addiction Treatment. Research Update in the Addictions


2013 Conference Co-Director, Texas Addiction Research to Practice Conference: Learn How Science Can Improve Addiction Treatment. Research Updates and Experiential Clinical Workshops in Motivational Interviewing, Acceptance and Commitment Therapy, Medication-Assisted Treatment


2014 Conference Director, Texas Addiction Research to Practice Conference: Learn How Science Can Improve Addiction Treatment. Seeking Safety, an Evidence-Based and Trauma-Informed Addiction Treatment


2018 Texas Regional CTSA Consortium Opioid Workgroup

Texas Regional CTSA Consortium (TRCC), UTSW representative

National/International

2009 – 2014 CTN-0047 SMART-ED (Screening, motivational assessment, referral, and treatment in emergency departments) Protocol Development Team

NIDA’s Clinical Trials Network

2010 – present Publications Committee, volunteer reviewer (review manuscripts prior to journal submission)


2010 – 2014 Research Utilization Committee NIDA’s Clinical Trials Network

2010 – present Node Coordinator Workgroup NIDA’s Clinical Trials Network

Aug 2014 – Aug 2015

Chair Elect, Node Coordinator Workgroup NIDA’s Clinical Trials Network

2015 Cannabis Task Force NIDA’s Clinical Trials Network

Aug 2015 – Aug 2016

Chair, Node Coordinator Workgroup NIDA’s Clinical Trials Network

Mar 2016 – Mar 2019

Publications Committee, elected member (committee tasked with reviewing CTN manuscripts prior to journal submission)



Professional Societies [List all society committees, leadership, and course leadership roles here]

Dates Society Name, member

1998 – 2000 Southeastern Psychological Association

2002 – 2005 Association for Behavioral and Cognitive Therapies (named Association for Advancement of Behavior Therapy prior to 2005)

2003 – present American Psychological Association

APA Division 50: Society of Addiction Psychology (2014 – present)

2007 – present Association for Psychological Science

2018 – present Texas Research Society on Alcohol, Board Member

Grant Review Activities

Year(s) Name of Review Committee Organization

2015 Health Services Research National Medical Research Council, Ministry of Health, Singapore

Editorial Activities

Year(s) Journal Name

Editor/Associate Editor

none

Editorial Board

none

Ad Hoc Reviewer

2004 American Journal on Addictions

2008 Journal of Substance Abuse Treatment

2009 Journal of Consulting and Clinical Psychology

2010 Journal of Clinical Psychology; Journal of Substance Abuse Treatment

2011 Archives of Clinical Neuropsychology; BMC Psychiatry; The American Journal on Addictions

2012 The American Journal on Addictions; Journal of Substance Abuse Treatment (2); The American Journal of Drug and Alcohol Abuse

2013 Journal of Substance Abuse Treatment; The American Journal of Drug and Alcohol Abuse

2014 British Journal of Psychology (2); Journal of Ethnicity in Substance Abuse (2); Prevention Science (2); Psychology of Addictive Behaviors (3)


2015 Journal of Substance Abuse Treatment (2); Psychology of Addictive Behaviors; The American Journal of Drug and Alcohol Abuse (3)

2016 Addictive Behaviors (5); Journal of Substance Abuse Treatment (3); The American Journal of Drug and Alcohol Abuse; The American Journal on Addictions

2017 Addictive Behaviors (3); The American Journal of Drug and Alcohol Abuse

2018 Journal of Affective Disorders; Addictive Behaviors; The American Journal of Drug and Alcohol Abuse

2019 Journal of Substance Abuse Treatment (2)

Invited Lectures

Year(s) Title Location

International

none

National

2004 An Intern’s Perspective. Panel discussion, A. M. Zeiss and R. J. Seime (Co-Chairs), Internship Training Site Overview

Association for the Advancement of Behavior Therapy, New Orleans, LA

2013 Characteristics of Mexican American adolescents receiving treatment for “cheese” heroin dependence

Steering Committee meeting of NIDA’s National Drug Abuse Treatment Clinical Trials Network, Bethesda, MD

Regional/Local

2002 Addiction Severity Index: Key interviewing and coding issues

Salem Veterans Affairs Medical Center, Salem, VA

Sept 30, 2013 Invited Guest Lecturer: Undergraduate Abnormal Psychology

Southern Methodist University, Dallas, TX

Feb 13, 2014 Invited Guest Lecturer: Undergraduate Abnormal Psychology

Southern Methodist University, Dallas, TX

Feb 22, 2018 Texas Regional CTSA Consortium Opioid Workgroup Panel, speaker

Texas Regional CTSA Consortium Meeting, Houston, TX

Feb 27, 2019 Grand Rounds, Psychiatry Department. Methamphetamine: An Emerging Public Health Threat?

UT Southwestern Medical Center, Dallas, TX

Technological and Other Scientific Innovations n/a Service to the Community


Year(s) Role Organization / Institution

2011 – 2013 Volunteer, Green Champions (mission: improve environmental & sustainability practices on campus)

UT Southwestern Medical Center, Dallas, TX

2012 Volunteer, Earth Day Dallas UT Southwestern Medical Center & City of Dallas

2014 – 2015 Member, Dallas Area Drug Prevention Partnership (DADPP)

The Council on Alcohol and Drug Abuse, Dallas, TX

2018 – 2020 Board Member, Callier Parent Association Callier Child Development Program, Dallas, TX

Teaching Portfolio A. Medical and graduate school didactic and small group teaching

Date Title Location

n/a

B. Dissertation Committees

Date Student Name and Information Location

2011 – 2012 Jacqueline Braud Decision-making and neural dysfunction as predictors of relapse to substance use Proposal: December 2011 Defense: July 2012

University of Texas Southwestern Medical Center, Clinical Psychology Graduate Program, Dallas, TX

2015 – 2017 Chair

Allen Liao Anxiety and Anhedonia in Major Depressive Disorder: The Contributing Roles of Neuroticism, Cognitive Control, and Reward Learning Proposal: December 19, 2016 Defense: June 17, 2017


2015 – 2017 Chair

Bryan Jester Implementing Mental Health Screening Assessment and Navigation (MH-SCAN) in a Community Oncology Clinic: Evaluations and Efficacy* Proposal: October 18, 2016 Defense: June 21, 2017 *Selected for 2017 UT Southwestern Medical Center Clinical Psychology Doctoral Program



Student Dissertation Award and $500 prize to student

2017 – 2019 Chair

Natalie Benedetto Mental health navigation for depression in a community cancer clinic: Predictors of navigation engagement and response Proposal: February 6, 2019 Defense: July 9, 2019


C. Qualifying Examination Committees

Date Title Location

n/a

D. Committees concerned with medical and graduate student education

Date Title Location

Sept – Oct 2014

Medical school applicant interviewer: Conducted interviews on Saturdays and provided detailed, individualized evaluation


Sept 2016 Medical school applicant interviewer: Conducted interviews on Saturdays and provided detailed, individualized evaluation


E. Graduate Student Rotations

Date Trainee Name and Information Location

Feb – May 2014

Valerie Loehr; 5th year Clinical Psychology PhD student, Southern Methodist University. Clinical supervisor during pre-doctoral practicum rotation


June 2015 – May 2017

Allen Liao; Clinical Psychology PhD student, University of Texas Southwestern Medical Center. Research rotation supervisor


F. Medical student rotations Date Title Location

n/a

G. Graduate Student Trainees Date Trainee Name and Information Location


June 2015 – May 2017

Allen Liao; Clinical Psychology PhD student, University of Texas Southwestern Medical Center. Research mentor


Aug 2015 – May 2017

Bryan Jester; Clinical Psychology PhD student, University of Texas Southwestern Medical Center. Research mentor


Aug 2017 – July 2019

Natalie Benedetto; Clinical Psychology PhD student, University of Texas Southwestern Medical Center. Research mentor


H. Postgraduate medical education (Residency/Postdoctoral/Fellowship education) Date Title Location

Feb 12, 2008 Clinical Pastoral Education Seminar Series – Substance Abuse Treatment at the VA: Recommendations

Dallas Division of the North Texas Veterans Health Care System, Dallas, TX

Mar 8, 2011 PGY-2 Clinical Neuroscience class lecture – What’s the evidence: Comparative effectiveness of psychosocial treatments for addictive disorders


Mar 20, 2012 PGY-2 Clinical Neuroscience class lecture – What’s the evidence: Comparative effectiveness of psychosocial treatments for addictive disorders


2019 – 2020 Faculty Facilitator for the PGY2-4 Psychiatry Resident Journal Club – 10 monthly sessions


I. Postdoctoral Trainees (Residents, Postdocs, Fellows) Date Trainee Name and Information Location

July 2012 – June 2015

Adriane dela Cruz, MD, PhD; Psychiatry Resident, Research Rotation in the Mood Disorders Research Program and Clinic, addiction focus. Mentored addiction research (ad hoc).


Nov 2013 – Jan 2015

Joseph Trombello, PhD; Postdoctoral Fellow in the Mood Disorders Research Program and Clinic. Supervised clinical work and mentored (1 hour / week).


J. Other Date Training Location

2008 – 2015 Trained and supervised over 25 research coordinators and clinical interventionists, some



of whom then attended graduate or medical school (5), continued in research or clinical management at UT Southwestern (3) or other local or national institutions (8).

2010 – 2013 Trained, evaluated audiotaped sessions, certified, and annually re-certified approximately 25 assessors on the Timeline Followback, Stroop, and Wechsler Test of Adult Reading.


May 2011 CTN-0049 Project HOPE Intervention Training Team - Motivational Interviewing for HIV and Addiction Treatment Engagement.

Miami, FL

February 2017 CTN-0068 Lead Protocol Trainer for research staff at seven study sites

Dallas, TX

November 2018

Substance use disorder training for community health workers engaging with people recently released from jail

Dallas, TX

Research Support Completed

Grantor: NIDA, R01 DA014296 Title of Project: Reaching and Motivating Change in Teen Marijuana Smokers Principal Investigator: Roger Roffman, DSW Aim: Evaluate effectiveness of a 2-session motivational enhancement treatment compared to a 2-session health education control condition (plus 4 cognitive-behavioral sessions after both active treatments) and delayed treatment control condition for marijuana-using adolescents. Role: Scientific Consultant Dates: 9/1/01 – 5/1/04 Amount of award: $1,285,813 total costs

Grantor: Department of Veterans Affairs Health Services Research and Development Title of Project: Improving Substance Abuse Treatment Aftercare Adherence and Outcome Principal Investigator: Stephen J. Lash, PhD Aim: Evaluate effectiveness of using contracts, prompts, and reinforcers, compared to treatment as usual, to increase aftercare participation of graduates of a 28-day inpatient substance abuse treatment program. Role: Research Staff Trainer Dates: 9/1/01 – 5/1/04


Grantor: NIDA, R01 DA009425 Title of Project: Motivating Marijuana Cessation Principal Investigator: Roger Roffman, DSW Aim: Evaluate effectiveness of 2 vs. 6 sessions of motivational enhancement and cognitive-behavioral therapy for non-treatment seeking marijuana dependent adults. Role: Research Staff Trainer, Intervention Supervisor Dates: 9/1/01 –5/1/04 Amount of award: $933,355 total costs

Grantor: NIDA, R01 DA0145050 Title of Project: Marijuana Dependence Treatment PRN Principal Investigator: Roger Roffman, DSW Aim: Evaluate effectiveness of 9 sessions vs. treatment as needed (prn) in a treatment-seeking, marijuana-using sample, using motivational enhancement therapy, cognitive-behavioral skills training, and case management. Role: Research Staff Trainer, Intervention Supervisor Dates: 9/1/01 –5/1/04 Amount of award: $1,554,721 total costs

Grantor: Virginia Tech Graduate Student Assembly Graduate Research Development Project Grant Title of Project: Study of Pet Owners That Smoke (SPOTS) Principal Investigator: Robrina Walker, MS Aim: Pilot study evaluating one session of motivational enhancement therapy vs. assessment only on smoking outcomes in a community sample of cigarette smokers. Role: PI Dates: 1/05 – 5/05 Amount of award: $500 (maximum amount)

Grantor: NIDA, U10DA020024 Title of Project: Clinical Trials Network – The North Texas Node Principal Investigator: Bryon Adinoff, MD Aim: One of 13 Nodes in a research network collaborating to evaluate behavioral, pharmacological, and integrated treatment for addictive disorders within specialty care settings. Role: Scientific Director, Training Director, Node Coordinator Dates: 10/1/08 – 8/31/10 Amount of award: $5,091,374 total costs

Grantor: NIDA, U10DA020024 Title of Project: NIDA Clinical Trials Network Protocol 0031 Stimulant Abuser Groups to Engage in 12-Step (STAGE-12) Principal Investigator: Bryon Adinoff, MD Aim: Randomized clinical trial comparing 12-Step Facilitation to treatment as usual in outpatient stimulant abuse treatment.


Role: Site Co-Investigator, Research Staff Trainer Dates: 10/1/08 – 08/31/10 Amount of award: $547,789 total costs

Grantor: NIDA U10DA020024 Title of Project: NIDA Clinical Trials Network Protocol 0031A Evaluation of Neurocognitive Function, Oxidative Damage, and Their Association with Treatment Outcomes in Methamphetamine and Cocaine Abusers Principal Investigator: Bryon Adinoff, MD Aim: Evaluate the association of baseline neurocognitive function and oxidative damage with substance abuse treatment completion and stimulate use outcomes. Role: Site Co-Investigator, Research Staff Trainer Dates: 10/1/08 – 08/31/10 Amount of award: $0; Sub-study to Protocol 0031

Grantor: Department of Veterans Affairs, VA Merit Review Grant Title of Project: Trauma, Stress, and Persistence of HPA Axis Dysregulation in Alcoholism Principal Investigator: Bryon Adinoff, MD Aim: Evaluate moderating effects of stress, trauma, and alcohol use upon pituitary-adrenal axis sensitivity in one-month abstinent alcohol-dependent men and sex-matched controls, and the persistence of HPA axis dysregulation with continued abstinence. Role: Research Staff Supervisor, Assessment Trainer Dates: 10/1/08 – 10/31/10

Grantor: NIAAA, U01 AA016668 Title of Project: Stress, HPA Axis Dysfunction, and Relapse in Alcoholism Principal Investigator: Bryon Adinoff, MD Aim: Assess the contribution of trauma, stress, and alcohol use upon pituitary-adrenocortical functioning in alcohol dependence and prospective relapse. Role: Research Staff Supervisor, Assessment Trainer Dates: 10/1/08 – 10/31/10 Amount of award: $1,018,499 total costs

Grantor: NIDA, R01 DA023203 Title of Project: Impulsivity, Neural Deficits, and Cocaine Relapse Principal Investigator: Bryon Adinoff, MD Aim: Evaluate relationship between neurobiologic and neurocognitive measures of disinhibition and decision-making to prospective relapse. Role: Research Staff Supervisor, Assessment Trainer Dates: 10/1/08 – 10/31/10 Amount of award: $909,858 total costs

Grantor: NIDA, U10DA020024


Title of Project: NIDA Clinical Trials Network Protocol 0044 Web Delivery of Evidence Based Psychosocial Treatment for Substance Abuse Disorder Principal Investigator: Madhukar Trivedi, MD Aim: Randomized clinical trial comparing computerized delivery of psychosocial treatment to treatment as usual in outpatient drug abuse treatment. Role: Site Co-Investigator Dates: 9/1/09 – 6/31/12 Amount of award: $603,644 total costs

Grantor: NIDA, U10DA020024 Title of Project: NIDA Clinical Trials Network Protocol 0037 Stimulant Reduction Intervention using Dosed Exercise – Lead Investigative Team Principal Investigator: Madhukar Trivedi, MD Aim: Multi-site, randomized clinical trial comparing a dosed exercise intervention to health education, both of which are added to residential drug abuse treatment as usual, for stimulant users. Role: Co-Investigator, National Research Staff Training Director (9 sites) Dates: 12/1/09 – 5/31/16 Amount of award: $3,869,119 total costs

Grantor: NIDA, U10DA020024 Title of Project: NIDA Clinical Trials Network Protocol 0037 Stimulant Reduction Intervention using Dosed Exercise Principal Investigator: Madhukar Trivedi, MD Aim: Multi-site, randomized clinical trial comparing a dosed exercise intervention to health education, both of which are added to residential drug abuse treatment as usual, for stimulant users. Role: Site PI (Dallas site), Site Co-Investigator (Houston site) Dates: 12/1/09 – 4/30/13 Amount of award: $821,899 total costs

Grantor: NIDA, U10DA020024 Title of Project: NIDA Clinical Trials Network Protocol 0046 Smoking Cessation and Stimulant Treatment: Evaluation of the Impact of Concurrent Outpatient Smoking Cessation and Stimulant Treatment on Stimulant Dependence Principal Investigator: Madhukar Trivedi, MD Aim: Multi-site, randomized clinical trial to determine the impact on stimulant use outcomes of providing smoking cessation treatment in outpatient drug abuse treatment. Role: Site PI Dates: 3/1/10 – 8/31/12 Amount of award: $840,072 total costs

Grantor: NIDA, U10DA020024 Title of Project: Clinical Trials Network – The Texas Node [first competing continuation] Principal Investigator: Madhukar Trivedi, MD


Aim: One of 13 Nodes in a research network collaborating to evaluate behavioral, pharmacological, and integrated treatment for addictive disorders. Role: Scientific Director Dates: 9/1/10 – 8/31/15 Amount of award: $3,913,312 total costs

Grantor: NIDA, U10DA020024 Title of Project: NIDA Clinical Trials Network Protocol 0048 CURB – Cocaine Use Reduction with Buprenorphine Principal Investigator: Madhukar Trivedi, MD Aim: Multi-site, double-blinded, randomized clinical trial comparing buspirone to placebo for cocaine dependence. Role: Site Co-Investigator (San Antonio site) Dates: 2/1/11 – 6/30/13 Amount of award: $1,206,000 total costs

Grantor: NIDA, U10DA020024 Title of Project: NIDA Clinical Trials Network Protocol 0048-A-1 – Genetics Protocol of the Cocaine Use Reduction with Buprenorphine (CURB) Study Principal Investigator: Madhukar Trivedi, MD Aim: Test the association of specific genetic markers with the efficacy of buprenorphine and naltrexone for individuals with cocaine use disorder enrolled in the CTN-0048 CURB trial. Role: Co-Investigator, National Project Director (9 sites) Dates: 8/1/11 – 4/30/13 Amount of award: $0; Sub-study to Protocol 0048

Grantor: NIDA, U10DA020024 Title of Project: NIDA Clinical Trials Network Protocol 0049 Project Hope – Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users Principal Investigator: Madhukar Trivedi, MD Aim: Multi-site, randomized clinical trial comparing treatment as usual, patient navigation, and patient navigation with contingency management for HIV positive substance users. Role: Site Co-Investigator Dates: 1/1/12 – 5/31/15 Amount of award: $2,407,426 total costs

Grantor: NIDA, U10DA020024 Title of Project: NIDA Clinical Trials Network Protocol 0052 BRAC – A randomized controlled evaluation of buspirone for relapse prevention in adults with cocaine dependence Principal Investigator: Madhukar Trivedi, MD Aim: Multi-site, double-blinded, randomized clinical trial comparing buspirone to placebo for cocaine dependence (pilot study). Role: Site PI


Dates: 4/1/12 – 8/31/13 Amount of award: $640,000 total costs

Grantor: NIDA, U10DA020024 Title of Project: NIDA Clinical Trials Network Protocol 0054 ADAPT – Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder Principal Investigator: Madhukar Trivedi, MD Aim: Multi-site clinical trial evaluating the safety and efficacy of depot naltrexone plus oral bupropion for methamphetamine dependence. Role: Site PI Dates: 9/1/13 – 2/28/15 Amount of award: $687,100 total costs

Grantor: NIDA, U10DA020024 Title of Project: NIDA Clinical Trials Network Protocol 0053 ACCENT – Achieving Cannabis Cessation—Evaluating N-Acetylcysteine Treatment Principal Investigator: Madhukar Trivedi, MD Aim: Multi-site, placebo-controlled, randomized clinical trial comparing acetyl cysteine to placebo for marijuana dependence. Role: Site Co-Investigator (San Antonio site) Dates: 11/1/13 – 10/31/15 Amount of award: $800,088 total costs

Grantor: NIDA, 2UG1 DA020024-S Title of Project: NIDA Clinical Trials Network Protocol 0064 Hepatitis C Virus Care Principal Investigator: Madhukar Trivedi, MD Aim: Multi-site, randomized clinical trial comparing treatment as usual and care facilitation for HCV positive substance users who are also HIV positive. Role: Site Co-Investigator Dates: 11/1/15 – 5/31/18 Amount of award: $342,989 FY16 total costs; $469,031 FY17 total costs; $239,865 FY18 total costs

Current

Grantor: NIDA, 2UG1 DA020024 [second competing continuation] Title of Project: Clinical Trials Network – The Texas Node Principal Investigator: Madhukar Trivedi, MD Aim: One of 13 Nodes in a research network collaborating to evaluate behavioral, pharmacological, and integrated treatment for addictive disorders within healthcare and specialty care settings. Role: Co-Investigator Dates: 9/1/15 – 5/31/20 Amount of award: $3,890,574 FY15-FY20 total costs


Grantor: NIDA, 2UG1 DA020024-S1, -S2, -S3 Title of Project: NIDA Clinical Trials Network Protocol 0068 Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT-2) Principal Investigator: Madhukar Trivedi, MD Aim: Multi-site, double blind, placebo controlled, randomized clinical trial evaluating the efficacy of extended release naltrexone plus bupropion as a combination pharmacotherapy for methamphetamine use disorder. Role: Co-Lead Investigator, National Project Director Dates: 10/1/15 – 5/31/20 Amount of award: $192,000 FY16 total costs; $724,026 FY17 total costs; $553,813 FY18 total costs; $2,476,167 FY19 total costs

Grantor: NIDA, R34 DA045592-01A1 Title of Project: A community-clinic collaboration to improve outcomes in HIV+ substance users released from jail Principal Investigator: Ank Nijhawan, MD, MPH Aim: Develop, refine, and pilot a community re-entry intervention program for HIV+ substance users who are being released from jail. Role: Co-Investigator Dates: 4/1/18 – 2/28/21 Amount of award: $729,000 total costs; $243,000 FY18 (4/1/18-2/28/19) total costs

Grantor: NIDA, 2UG1 DA020024-S Title of Project: NIDA Clinical Trials Network Protocol 0090 Innovatively Increasing PCP Prescribing of Buprenorphine: Measurement Based Care and Integrated Electronic Solution Principal Investigator: Madhukar Trivedi, MD Aim: Develop an electronic solution to screen and identify patients with problematic opioid use and to guide providers in using buprenorphine for measurement-based care of opioid use disorders (OUD) in primary care. Assess provider acceptability of the OUD electronic solution, evaluate the impact of the OUD screening on case identification and treatment, assess barriers and facilitators of implementing buprenorphine treatment, develop a refinement and dissemination strategy. Role: Co-Investigator Dates: 2/8/19 – 5/31/19 Amount of award: $304,955 FY19 total costs

Pending Bibliography Peer-Reviewed Publications

Original Research Articles


1. Walker, R., Rosvall, T., Field, C., Allen, S., McDonald, D., Salim, Z., Ridley, N., Adinoff, B. (2010). Disseminating contingency management to increase attendance in two community substance abuse treatment centers: Lessons learned. Journal of Substance Abuse Treatment, 39(3), 202 – 209. PMID:20598838. PMCID:PMC2937094. DOI: 10.1016/j.jsat.2010.05.010

*included in UpToDate “Contingency management for substance use disorders: Efficacy, implementation, and training,” Topic 103550, Version 7.0, accessed 2/21/2018.

2. Bogenschutz, M. P., Donovan, D. M., Adinoff, B., Crandall, C., Forcehimes, A. A., Lindblad, R., Mandler, R. N., Oden, N. L., Perl, H. I., Walker, R. (2011). Design of NIDA CTN protocol 0047: Screening, motivational assessment, referral, and treatment in emergency departments (SMART-ED). American Journal of Drug and Alcohol Abuse, 37(5), 417-425. PMID:21854285. PMCID:PMC3168577. DOI: 10.3109/00952990.2011.596971

3. Trivedi, M. H., Greer, T. L., Grannemann, B. D., Church, T. S., Somoza, E., Blair, S. N., Szapocznik, J., Stoutenberg, M., Rethorst, C., Warden, D. Ring, K. M., Walker, R., Morris, D. W., Kosinski, A. S., Kyle, T., Marcus, B., Crowell, R., Nunes, E., Oden, N. (2011). Stimulant reduction intervention using dosed exercise (STRIDE) – CTN 0037: Study protocol for a randomized controlled trial. Trials, 12(206), 1-15. PMID:21929768. PMCID:PMC3191354. DOI: 10.1186/1745-6215-12-206

4. Walker, R., Hunt, Y. M., Olivier, J., Grothe, K. B., Dubbert, P. M., Burke, R. S., Cushman, W. C. (2012). Descriptive characteristics and cluster analysis of male veteran hazardous drinkers in an alcohol moderation intervention. The American Journal on Addictions, 21(4), 335-342. PMID:22691012. PMCID: not applicable. DOI: 10.1111/j.1521-0391.2012.00247.x

5. Greer, T. L., Ring, K. M., Warden, D., Grannemann, B. D., Church, T. S., Somoza, E., Blair, S. N., Szapocznik, J., Stoutenberg, M., Rethorst, C., Walker, R., Morris, D. W., Kosinski, A. S., Kyle, T., Marcus, B., Crowell, B., Oden, N., Nunes, E., Trivedi, M.H. (2012). Rationale for using exercise in the treatment of stimulant use disorders. The Journal of Global Drug Policy and Practice, 6(1), 1-33. PMID:25364477. PMCID:PMC4214380.

6. Donovan, D. M., Bogenschutz, M. P., Perl, H., Forcehimes, A., Adinoff, B., Mandler, R., Oden, N., Walker, R. (2012). Study design to examine the potential role of assessment reactivity in the NIDA CTN Screening, Motivational Assessment, Referral and Treatment in Emergency Departments (SMART-ED) Protocol. Addiction Science & Clinical Practice, 7(16). PMID:23186329. PMCID:PMC3599426. DOI: 10.1186/1940-0640-7-16

7. Walker, R., Morris, D. W., Greer, T. L., Trivedi, M. H. (2014). Research staff training in a multisite randomized clinical trial: Methods and recommendations from the Stimulant Reduction Intervention using Dosed Exercise (STRIDE) trial. Addiction Research & Theory, 22(5), 407-415. PMID: 25379036. PMCID:PMC4217528. DOI: 10.3109/16066359.2013.868446


8. Denton, W. H., Adinoff, B. A., Lewis, D., Walker, R., Winhusen, T. (2014). Family discord is associated with increased substance use for pregnant substance users. Substance Use and Misuse, 49(3), 326-332. PMID:24106976. PMCID:PMC4109678. DOI: 10.3109/10826084.2013.840002

9. Walker, R., & Stephens, R. S. (2014). Protective behavioral strategies mediate problem-focused coping and alcohol use in college students. Addictive Behaviors, 39(6), 1033-1037. PMID:24629479. PMCID:not applicable. DOI: 10.1016/j.addbeh.2014.02.006.

10. Eames, S. F., Businelle, M. S., Suris, A., Walker, R., Rao, U., North, C. S., Xiao, H., Adinoff, B. (2014). Stress moderates the effect of childhood trauma and adversity on recent drinking in treatment-seeking alcohol-dependent men. Journal of Clinical and Consulting Psychology, 82(3), 441-447. PMID:24635549. PMCID:PMC4059595. DOI: 10.1037/a0036291

11. Wells, E. A., Donovan, D. M., Daley, D. C., Doyle, S., Brigham, G., Garrett, S. B., Hansten-Ingalsbe, M., Hatch-Maillette, M. A., Perl, H. I., Walker, R. (2014). Is level of exposure to a 12-Step facilitation therapy associated with treatment outcome? Journal of Substance Abuse Treatment, 47(4), 265-274. PMID:25064421. PMCID:PMC4138275. DOI: 10.1016/j.jsat.2014.06.003

12. LoBue, C., Cullum, M., Braud, J., Walker, R., Winhusen, T., Suderajan, P., Adinoff B. (2014). Optimal neurocognitive, personality and behavioral measures for assessing impulsivity in cocaine dependence. American Journal of Drug and Alcohol Abuse, 40(6), 455-462. PMID:25083938. PMCID:PMC4448965 DOI: 10.3109/00952990.2014.939752.

13. Walker, R., Maxwell, J. C., Adinoff, B., Carmody, T., Coton, C. E., Tirado, C. F. (2014). Characteristics of Mexican and Mexican American adolescents in treatment for “cheese” heroin use. Journal of Ethnicity in Substance Abuse, 13(3), 258-272. PMID:25176119. PMCID:PMC4151481. DOI: 10.1080/15332640.2014.883582.

14. dela Cruz, A., Bernstein, I. H., Greer, T. L., Walker, R., Rethorst, C. D., Grannemann, B., Carmody, T., Trivedi, M. H. (2014). Self-rated measure of pain frequency, intensity, and burden: Psychometric properties of a new instrument for the assessment of pain. Journal of Psychiatric Research, 59, 155-160. PMID:25194231. DOI: 10.1016/j.jpsychires.2014.08.003.

15. Sanchez, K., Walker, R., Campbell A. N. C., Greer T., Hu, M-C., Grannemann, B., Nunes E. V., Trivedi, M. H. (2014). Depressive symptoms and associated clinical characteristics in outpatients seeking community-based treatment for alcohol and drug problems. Substance Abuse. PMID: 25084694. PMCID:PMC4313559. DOI: 10.1080/08897077.2014.937845

16. Northrup, T. F., Stotts, A. L., Green, C., Potter, J. S., Marino, E. N., Walker, R., Weiss, R. D., Trivedi, M. (2015). Opioid withdrawal, craving, and use during and after outpatient buprenorphine stabilization and taper: A discrete survival and growth mixture model. Addictive Behaviors, 41, 20-28. PMID:25282598. PMCID:PMC4252696. DOI: 10.1016/j.addbeh.2014.09.021.


17. Northrup, T. F., Green, C., Walker, R., Greer, T., Trivedi, M. (2015). On the invariance of the Stimulant Craving Questionnaire (STCQ) across cocaine and methamphetamine users. Addictive Behaviors, 42, 144-147. PMID:25462663. PMCID:PMC4272872. DOI: 10.1016/j.addbeh.2014.11.020.

18. Sanchez, K., Chartier, K. G., Greer, T. L., Walker, R., Carmody, T., Rethorst, C. D., Ring, K. M., dela Cruz, A. M., Trivedi, M. H. (2015). Comorbidities and race/ethnicity among adults with stimulant use disorders in residential treatment. Journal of Ethnicity in Substance Abuse, 14(1), 79-95. PMID:25580933. PMCID:PMC4698967. DOI: 10.1080/15332640.2014.961109.

19. Mitchell, S. G., Schwartz, R. P., Alvanzo, A. A., Weisman, M., Kyle, T., Turrigiano, E., Gibson, M., Perez, E., McClure, E., Clingerman, S., Froias, A., Shandera, D., Walker, R., Babcock, D. L., Bailey, G. L., Miele, G. M., Kunkel, L. E., Norton, M., Stitzer, M. (2015). The use of technology in participant tracking and study retention: Lessons learned from a Clinical Trials Network study. Substance Abuse, 36(4), 420-426. PMID:25671593. PMCID:PMC4532645. DOI: 10.1080/08897077.2014.992565.

20. Adinoff, B., Carmody, T., Walker, R., Donovan, D. M., Brigham, G., Winhusen, T. (2016). Decision-making processes as predictors of relapse and subsequent use in stimulant dependent patients. American Journal of Drug and Alcohol Abuse, 42(1), 88-97. PMID:26743586. PMCID:PMC4817850. DOI: 10.3109/00952990.2015.1106550.

21. dela Cruz, A. M., Carmody, T., Greer, T. L., Rethorst, C. D., Warden, D., Walker, R., Trivedi, M. H. (2016). Baseline medical comorbidities in adults randomized in the STRIDE trial for psychostimulant use disorders. American Journal on Addictions, 25(3), 215-220. PMID:26991889. PMCID:PMC4818002. DOI: 10.1111/ajad.12363.

22. Mooney, L. J., Hillhouse, M. P., Thomas, C., Ang, A., Sharma, G., Terry, G., Chang, L., Walker, R., Trivedi, M., Croteau, D., Sparenborg, S., Ling, W. (2016). Utilizing a two-stage design to investigate the safety and potential efficacy of monthly naltrexone plus once-daily bupropion as a treatment for methamphetamine use disorder. Journal of Addiction Medicine, 10(4), 236-243. PMID:27379819. PMCID:PMC4969133. DOI: 10.1097/ADM.0000000000000218.

23. Warden, D., Sanchez, K., Greer, T., Carmody, T., Walker, R., dela Cruz, A., Toups, M., Rethorst, C., Trivedi, M. H. (2016). Demographic and clinical characteristics of current comorbid psychiatric disorders in a randomized clinical trial for adults with stimulant use disorders. Psychiatry Research, 246, 136-141. PMID:27693866. PMCID:PMC5437704. DOI: 10.1016/j.psychres.2016.09.007.

24. Northrup, T. F., Greer, T. L., Walker, R., Rethorst, C. D., Warden, D., Stotts, A. L., Trivedi, M. H. (2017). An ounce of prevention: A pre-randomization protocol to improve retention in substance use disorder clinical trials. Addictive Behaviors, 64, 137-142. PMID:27610591. PMCID:PMC5143209. DOI: 10.1016/j.addbeh.2016.08.040.


25. Adinoff, B., Leonard, D., Price, J., Javors, M., Walker, R., Brown, S., Xiao, H., Rao, U. (2017). Adrenocortical sensitivity, moderated by ongoing stress, predicts drinking intensity in alcohol-dependent men. Psychoneuroendocrinology, 76, 67-76. PMID:27888772. PMCID:PMC5272781 DOI: 10.1016/j.psyneuen.2016.10.011.

26. Levesque, A., Campbell, A. N. C., Pavlicova, M., Hu, M. C., Walker, R., McClure, E. A., Ghitza, U. E., Bailey, G., Stitzer, M., Nunes, E. V. (2017). Coping strategies as a mediator of internet-delivered psychosocial treatment: Secondary analysis from a NIDA CTN multisite effectiveness trial. Addictive Behaviors, 65, 74-80. PMID:27776269. PMCID:PMC5483182. DOI: 10.1013/j.addbeh.2016.09.012

27. Trivedi, M. H., Greer, T., Rethorst, C. D., Carmody, T., Granneman, B. D., Walker, R., Warden, D., Shores-Wilson, K., Stoutenberg, M., Oden, N., Silverstein, M., Hodgkins, C., Love, L., Seamans, C., Stotts, A., Causey, T., Szucs-Reed, R. P., Rinaldi, P., Myrick, H., Straus, M., Liu, D., Lindblad, R., Church, T., Blair, S. N., Nunes, E. V. (2017). Randomized trial comparing exercise to health education for stimulant use disorder: Results from STimulant Reduction Intervention using Dosed Exercise (CTN-0037; STRIDE). Journal of Clinical Psychiatry, 78(8), 1075-1082. PMID:28199070. PMCID:PMC5683711. DOI: 10.4088/JCP.15m10591

28. Sanchez, K., Greer, T. L., Walker, R., Carmody, T., Rethorst, C. D., Trivedi, M. H. (2017). Racial and ethnic differences in treatment outcomes among adults with stimulant use disorders after a dosed exercise intervention. Journal of Ethnicity in Substance Abuse, 16(4), 495-510. PMID: 28524806. PMCID:5694709. DOI:10.1080/15332640.2017.1317310.

29. Trombello, J., Carmody, T., Greer, T., Walker, R., Rethorst, C. Trivedi, M. H. (2017). Psychosocial relationship status and quality as predictors of intervention adherence and substance use outcomes: Results from the STRIDE (CTN-0037) study. Psychiatry Research, 254, 332-339. PMID: 28525788. PMCID:PMC5563976. DOI:10.1016/j.psychres.2017.04.062.

30. Howe-Martin, L., Jester, B., Walker, R., de la Garza, N., Jha, M., Tovian, C., Levinson, S., Argenbright, K., Trivedi, M. (2018). A pilot program for implementing Mental Health Screening & Navigation in a community-based cancer center. Psycho-Oncology, 27, 683-86. PMID:28295861. PMCID: not applicable. DOI: 10.1002/pon.4418

31. Trombello, J., Killian, M. O., Liao, A., Sanchez, S., Greer, T. L., Walker, R., Granneman, B., Rethorst, C. D., Carmody, T., Trivedi, M. H. (2018). Psychometrics of the self-report Concise Associated Symptoms Tracking Scale (CAST-SR): Results from the STRIDE (CTN-0037) study. Journal of Clinical Psychiatry, 79(1), 17m11707. PMID:29325238. PMCID:PMC5932219. DOI:10.4088/JCP.17m11707

32. Carmody, T., Greer, T. L., Walker, R., Rethorst, C. D., Trivedi, M. H. (2018). A Complier Average Causal Effect Analysis of the Stimulant Reduction Intervention using Dosed Exercise Study. Contemporary Clinical Trials Communications, 10(1-8). Open access. PMID:29682627. PMCID:PMC5898532. DOI:10.1016/j.conctc.2018.02.001


33. Sanchez, K., Killian, M. O., Mayes, T. L. Greer, T. L., Trombello, J. M., Lindblad, R., Granneman, B. D., Carmody, T. J., Rush, A. J., Walker, R., Trivedi, M. H. (2018). A psychometric evaluation of the Concise Health Risk Tracking Self-Report (CHRT-SR) – a measure of suicidality – in patients with stimulant use disorder. Journal of Psychiatric Research, 102, 65-71. PMID:29626753. doi: 10.1016/j.jpsychires.2018.03.012

34. Nijhawan, A.E., Metsch, L.R., Zhang, S., Feaster, D.J., Gooden, L., Jain, M.K., Walker, R., Huffaker, S., Mugavero, M.J., Jacobs, P., Armstrong, W.S., Daar, E.S., Sullivan, M., Rio, C.d., Halm, E.A. (2019). Clinical and sociobehavioral prediction model of 30-day hospital readmissions among people with HIV and substance use disorder: Beyond electronic health record data. Journal of Acquired Immune Deficiency Syndromes, 80, 330-341. PMID:30763292. doi: 10.1097/QAI.0000000000001925

35. Price J.L., Frazier I.R., Lewis B., Walker R., Javors M.A., Nixon S.J., Adinoff B. (2019). Differences in pituitary-adrenal reactivity in Black and White men with and without alcohol use disorder. Psychoneuroendocrinology, 100, 180-189. PMID:30347319. PMCID:PMC6333532. doi: 10.1016/j.psyneuen.2018.10.004

36. Liao, A., Walker, R., Carmody, T., Cooper, C., Shaw, M.A., Grannemann, B.G., Adams, P., Bruder, G., McInnis, M., Webb, C., Dillon, D., Pizzagalli, D., Phillips, M., Kurian, B.T., Fava, M., Parsey, R.V., McGrath, P., Weissman, M., Trivedi, M. (2019). Anxiety and anhedonia in depression: Associations with neuroticism and cognitive control. Journal of Affective Disorders, 245, 1070-1078. PMID:30699849. doi: 10.1016/j.jad.2018.11.072

37. Walker, R., Northrup, T.F., Tillitski, J., Bernstein, I., Greer, T.L., Trivedi, M.H. (2019). The Stimulant Selective Severity Assessment: A replication and exploratory extension of the Cocaine Selective Severity Assessment. Substance Use and Misuse, 54(3), 351-361. PMID:30657406. PMCID:PMC6438747. NIHMS1507508. doi: 10.1080/10826084.2018.1467453

38. Walker, R., Hillhouse, M., Perrochet, B., Sparenborg, S., Mooney, L., Ling, W. (2019). Medication adherence monitoring using smartphone video dosing in a study of monthly naltrexone plus once-daily bupropion for methamphetamine use disorder. Journal of Addiction Medicine. PMID:30724759. NIHMS1519060. doi: 10.1097/ADM.0000000000000509

39. Vidot, D., Rethorst, C.D., Carmody, T.J., Stoutenberg, M., Walker, R., Greer, T.L., Trivedi, M.H. (2019). Acute and long-term cannabis use among stimulant users: Results from CTN-0037 stimulant reduction intervention using dosed exercise (STRIDE) randomized controlled trial. Drug and Alcohol Dependence, 200, 139-144. PMID: 31129484. Doi: 10.1016/j.drugalcdep.2019.02.032

Reviews, Chapters, Monographs, and Editorials none Books/Textbooks none


Case Reports none Letters to the Editor none Proceedings of Meetings

1. Walker, N. R. (2009, June). Relationships among general coping, alcohol-specific coping, and alcohol use in a college student population. Alcoholism: Clinical and Experimental Research, 33(s1), 345A.

2. Fielding, S. K., Shalvoy, A. M., Leachman, L. L., Minhajuddin, A., Walker, N. R., North, M. A., Rao, U., Xiao, H., Adinoff, B. (2010, June). Antisocial personality characteristics and alcohol use as predictors of cortisol reactivity to a behavioral stressor. Alcoholism: Clinical and Experimental Research, 34(6), 43A.

3. Leachman, L. L., Fielding, S. K., Shalvoy, A. M., Walker, N. R., Minhajuddin, A., North, C. S., Rao, U., Xiao, H., Adinoff, B. (2010, June). Relationship of self-reported childhood trauma to personality characteristics in alcohol-dependent men. Alcoholism: Clinical and Experimental Research, 34(6), 169A.

4. Shalvoy, A. M., Leachman, L. L., Walker, N. R., Minhajuddin, A., North, C. S., Javors, M. A., Rao, U., Xiao, H., Adinoff, B. (2010, June). Antisocial personality characteristics and alcohol use as predictors of cortisol reactivity to a behavioral stressor. Alcoholism: Clinical and Experimental Research, 34(6), 168A.

5. Adinoff, B. A., Yang, H., Walker, R., Rao, U., North, C. S., Xiao, H., Businelle, M. S. (2011, June). Unraveling the risks: Stress, trauma and alcohol effects upon biologic stress response systems and prospective relapse in alcohol dependent subjects. Alcohol, 45(3), 280.

6. Adinoff, B. A., Businelle, M. S., Walker, R., Yang, H., Javors, M. A., Rao, U., North, C. S., Devous, M. D., Briggs, R. W., Xiao, H., Morrow, A. L. (2012, June). Stress, trauma and alcohol effects upon biologic stress response systems and prospective relapse in alcohol dependent subjects. Alcoholism: Clinical and Experimental Research, 36, 356A.

7. Braud, J., Harris, T. S., Devous, M. D., Spence, J., Briggs, R., Walker, R., Cullum, M., Adinoff, B. (2012, June). Neural alterations during a decision-making task in cocaine-addicted subjects. Alcoholism: Clinical and Experimental Research, 36, 392A.

8. Forcehimes, A., Crandall, C., Bogenschutz, M., Donovan, D., Lindblad, R., Walker, R. (2012, October). Factors associated with effective implementation of screening, brief intervention, and referral to treatment in the emergency department. Addiction Science & Clinical Practice, 7(s1):A78.


9. McHugh, M., Gu, H., Yang, Y., Braud, J., Devous, M., Briggs, R., Walker, N. R., Adinoff, B., Stein, E. (2012, November). Resting state network dynamics predict relapse in cocaine-dependent Individuals. Neuropsychopharmacology, 38, S248. doi:10.1038/npp.2012.220

10. Gu H., McHugh M., Yang Y., Shope C., Braud J., Devous M., Briggs R., Walker N. R., Cullum M., Stein E., Adinoff B. (2012, December). Resting Regional Cerebral Blood Flow to Predict Relapse in Cocaine Dependent Individuals. Neuropsychopharmacology, 38, S274. doi:10.1038/npp.2012.220

11. Stotts, A., Northrup T., Potter J. S., Marino E. N., Walker R., Trivedi M., Weiss R. (2014, July). Relations between craving and withdrawal and time to first opioid use among prescription opioid abusers initiating buprenorphine detoxification. Drug and Alcohol Dependence, 140:e218.

12. Nielsen, D. A., Walker, R., Hamon, S. C., Hardin, M. H., Ling, W., Kosten, T. R. (2014, November). Cocaine addiction pharmacogenetics of buprenorphine therapy. Program No. 232.18. Neuroscience Meeting Planner Online. Washington, DC: Society for Neuroscience.

13. Sanchez, K., Chartier, K. G., Greer, T. L., Walker, R., Carmody, T., Rethorst, C. D., Ring, K., dela Cruz, A. M., Trivedi, M. H. (2015, January). Race and ethnicity differences among adults with stimulant use disorders in a residential treatment setting: A baseline analysis of the STRIDE cohort. Drug and Alcohol Dependence, 146:e88. DOI:10.1016/j.drugalcdep.2014.09.608

14. Nielsen, D. A., Walker, R., Hamon, S. C., Harding, M. J., Ling, W., Kosten, T. R. (2015, January). Pharmacogenetics of buprenorphine therapy of cocaine addiction. Drug and Alcohol Dependence, 146:e51-e52. DOI:10.1016/j.drugalcdep.2014.09.511

15. Annon, J., Millhouse, M., Thomas, C., Mooney, L., Hasson, A., Walker, R., Chang, L., Sparenborg, S., Lindblad, R., VanVeldhuisen, P., Ling, W. (2015, November). A new study methodology: ADAPT, the short, staged trial. Drug and Alcohol Dependence, 156:e7-e8. DOI:10.1016/j.drugalcdep.2015.07.939

16. Oyama, M., Hillhouse, M., Thomas, C., Annon, J., Hasson, A., Mooney, L., Walker, R., Chang, L., Sparenborg, S., Ling, W. (2015, November). Using cellphone technology to monitor and increase dosing adherence. Drug and Alcohol Dependence, 156:e168. DOI:10.1016/j.drugalcdep.2015.07.457.

17. Hillhouse, M., Ang, A., Thomas, C., Nielsen, S., Walker, R., Potter, J., Brigham, G., Stout, S., Weimer, M., Winhusen, T. (2015, November). Opioid use severity and treatment outcome in cocaine-dependent participants with a history of opioid abuse/dependence. Drug and Alcohol Dependence, 156:e95. DOI:10.1016/j.drugalcdep.2015.07.1176.

18. Frimpong, J. A., Shiu, K., Feaster, D. J., Duan, R., Matheson, T., DeMicco, E., Sorenson, J., Walker, R., Drainoni, M., Gaskin, S., Stitzer, M.L., Mandler, R., Farber, E., del Rio, C., Metsch, L. R. (2015, November). Substance use disorders treatment history among hospitalized HIV-infect substance users in 11 US cities. Drug and Alcohol Dependence, 156:e75. DOI:10.1016/j.drugalcdep.2015.07.1121.


19. Price, J.L., Frazier, I.R., Javors, M.A., Walker, R., Rao, U., Nixon, S.J., Adinoff, B. (2017, May). Racial differences in stress-induced HPA reactivity in alcohol-dependent men. Alcohol, 60, 237.

20. Price, J.L., Acevedo, S., Javors, M.A., Walker, R., Goldman, D., Nixon, S. J., & Adinoff, B. (2017, June). CRHR1 genotype on non-reactive cortisol and ACTH in healthy controls and alcohol dependent men. Alcoholism: Clinical and Experimental Research, 41, S1, 473.

21. Price, J.L., Frazier, I.R., Javors, M.A., Walker, R., Nixon, S. J., & Adinoff, B. (2017, June). Differences in HPA dysregulation between African American and Caucasian alcohol-dependent men. Alcoholism: Clinical and Experimental Research, 41, S1, 851.

Clinical Practice Guidelines none

Non-peer reviewed scientific or medical publications/materials in print or other media

1. Walker, N. R. (2003, Summer). Understanding health implications of human-animal relationships using a functional support model. Newsletter of the American Association of Human-Animal Bond Veterinarians, 9, 11.

2. Walker, R. (2004, November). An Intern’s Perspective. In A. M. Zeiss and R. J. Seime (Co-Chairs), Internship Training Site Overview. Panel discussion conducted at the annual meeting of the Association for the Advancement of Behavior Therapy, New Orleans, LA. (summarized in: Zeiss, A. M. (2005, March). Training program update: An overview of the 21st annual AABT internship panel and overview. the Behavior Therapist, 28(3), 54-56.)

Presentations

1. Walker, N. R., Stearns, D., Poole, A., & Ludwig, T. D. (1999, March). Peer agents, pledge

cards, and accessibility to promote bike helmet use. In T. D. Ludwig (Chair), Reducing adolescent risk behavior: Alcohol, bike helmet use and driving safety. Symposium conducted at the annual meeting of the Southeastern Psychological Association, Savannah, GA.

2. Walker, R. (2004, November). An Intern’s Perspective. In A. M. Zeiss and R. J. Seime (Co-Chairs), Internship Training Site Overview. Panel conducted at the annual meeting of the Association for the Advancement of Behavior Therapy, New Orleans, LA. [Invited presentation.]

3. Jones, M. E., Lozano, B. E., & Walker, N. R. (2004, November). Therapeutic alliance and outpatient substance abuse aftercare: Mediation between intervention and treatment outcome? In S. J. Lash (Chair) and D. Kivlahan (Discussant), Behavioral contracting, prompting and reinforcing substance abuse continuing care. Symposium conducted at the annual meeting of the Association for the Advancement of Behavior Therapy, New Orleans, LA.


4. Stephens, R. S., Roffman, R. A., Walker, N. R., DeMarce, J., Lozano, B. E., Jones, M. E. (2006, January). Marijuana dependence treatment for adults, PRN. Presentation at the annual International Conference on Treatment of Addictive Behaviors, Albuquerque, NM.

5. Adinoff, B. A., Yang, H., Walker, R., Rao, U., North, C. S., Xiao, H., Businelle, M. S. (2011, June). Unraveling the risks: Stress, trauma and alcohol effects upon biologic stress response systems and prospective relapse in alcohol dependent subjects. Presentation at the Alcoholism and Stress Conference, Volterra, Italy.

6. Forcehimes, A. A., Crandall, C., Bogenschutz, M. P., Donovan, D., Lindblad, R., & Walker, R. (2011, September). Factors associated with effective implementation of SBIRT delivered in an emergency department setting. Presentation at the 8th Annual International Network on Brief Interventions for Alcohol Problems (INEBRIA) Conference, Boston, MA.

7. Denton, W. H., Winhusen, T., Lewis, D., Walker, R., Adinoff, B. H. (2011, October). Family discord is associated with increased substance use for pregnant substance users. Presentation at the International Association for Relationship Research Mini-Conference on Health, Emotions and Relationships, Tucson, AZ.

8. Adinoff, B. A., Businelle, M. S., Walker, R., Yang, H., Javors, M. A., Rao, U., North, C. S., Devous, M. D., Briggs, R. W., Xiao, H., Morrow, A. L. (2012, June). Stress, trauma and alcohol effects upon biologic stress response systems and prospective relapse in alcohol dependent subjects. Symposium conducted at the annual scientific meeting of the Research Society on Alcoholism, San Francisco, CA.

9. Lindblad, R., Bogenschutz, M. P., Donovan, D., Rothwell, R. S., Walker, R., Neal, O., Perl, H., Crandall, C. (2012, September). Screening, enrollment, and assessment in the SMART-ED study. Presentation at the 9th Annual International Network on Brief Interventions for Alcohol Problems (INEBRIA) Conference, Barcelona, Spain.

10. Bogenschutz, M. P., Donovan, D., Forcehimes, A. A., Crandall, C., Mandler, R., Perl, H., Lindblad, R., Oden, N., & Walker, R. (2012, September). Brief intervention research in the medical emergency department: Recruitment, assessment, and intervention in NIDA CTN protocol. Presentation at the 9th Annual International Network on Brief Interventions for Alcohol Problems (INEBRIA) Conference, Barcelona, Spain.

11. Walker, R. (2013, March). Characteristics of Mexican American adolescents receiving treatment for “cheese” heroin dependence. In the CTN Race and Ethnic Minorities Research Symposium conducted at the annual Steering Committee meeting of NIDA’s National Drug Abuse Treatment Clinical Trials Network, Bethesda, MD. (Invited presentation)

12. Nielsen, D. A., Walker, R., Hamon, S. C., Harding, M. J., Ling, W., Kosten, T. R. (2014, June). Pharmacogenetics of buprenorphine therapy of cocaine addiction. Presentation at the annual meeting of the College on Problems of Drug Dependence, San Juan, Puerto Rico.


13. Howe-Martin, L., Jester, B., Walker, R., de la Garza, N., Jha, M., Argenbright, K., & Trivedi, M. (2016, March). A Pilot Program for Implementing Mental Health Screening & Mental Health Navigation Services in a Community-Based Cancer Center. Selected for Oral Presentation as one of the best five innovative clinical interventions at the 13th annual Conference of the American Psychosocial Oncology Society, San Diego, CA.

14. Sullivan, E., Neumann, C., Cullum, M., Walker, R., Adinoff, B. (2017, February). Assessing impulsivity in cocaine users utilizing hot and cool measures of executive functioning. International Neurological Society, New Orleans, LA.

15. Deng, H., Hamon, S., Nielsen, E., Walker, R., Kosten, T., Nielsen, D. (2017, May). Moderation of buprenorphine therapy efficacy for cocaine dependence by variation of the preprodynorphin gene. American Psychological Association, San Diego, CA.

16. Nielsen, D.A., Walker, R., Harding, M.J., Ling, W., Kosten, T.R. (2018, June). Moderation of buprenorphine therapy efficacy for cocaine dependence by variation of the preprodynorphin gene. Presentation at the annual meeting of the College on Problems of Drug Dependence, San Diego, CA.

Posters

1. Lash, S. J., Stephens, R. S., Burden, J. L., Grambow, S. C., Horner, R. D., Walker, N. R.,

DeMarce, J., Jones, M. E., Lozano, B. E. (2002, November). Contracting, prompting and reinforcing substance abuse aftercare attendance: Three month outcomes of a VA HSR&D clinical trial. Poster presented at the annual meeting of the Association for the Advancement of Behavior Therapy, Reno, NV.

2. Donovan, K., Cooper, L., Fournier, A., Walker, N. R. (2002, November). Brief group treatment for dual diagnosis offenders on probation. Poster presented at the annual meeting of the Association for the Advancement of Behavior Therapy, Reno, NV.

3. Stephens, R. S., Roffman, R., Fearer, S. A., Walker, N. R., Williams, C. D. (2002, November). The marijuana check-up: Augmenting the impact of a brief intervention for ambivalent marijuana users. Poster presented at the annual meeting of the Association for the Advancement of Behavior Therapy, Reno, NV.

4. Fearer, S. A., Walker, N. R., Stephens, R. S., Roffman, R., Williams, C. D. (2002, November). Predicting change in the marijuana check-up. Poster presented at the annual meeting of the Association for the Advancement of Behavior Therapy, Reno, NV.

5. Walker, N. R., DeMarce, J., Jones, M. E., Lozano, B. E., Stephens, R. S., Lash, S. J., Burden, J. L. (2002, November). Development of an aftercare self-efficacy questionnaire: Validity and ability to predict aftercare attendance. Poster presented at the annual meeting of the Association for the Advancement of Behavior Therapy, Reno, NV.

6. Walker, N. R., Fearer, S. A., Stephens, R. S., Roffman, R., Williams, C. D. (2002, November). Measuring motivation for marijuana change. Poster presented at the annual meeting of the Association for the Advancement of Behavior Therapy, Reno, NV.


7. Walker, N. R. & Stephens, R. S. (2002, November). Understanding self-efficacy for alcohol use: The roles of self-monitoring and hypothesized source variables. Poster presented at the annual meeting of the Association for the Advancement of Behavior Therapy, Reno, NV.

8. Lozano, B. E., Roffman, R., Tsuru, W., Walker, N. R., Stephens, R. S. (2004, November). Marijuana dependent clients’ outcome goals: Understanding shifts between abstinence and moderation. Poster presented at the annual meeting of the Association for the Advancement of Behavior Therapy, New Orleans, LA.

9. Stephens, R. S., Roffman, R., Walker, N. R., Fearer, S. A. (2004, November). Motivational enhancement therapy with marijuana users low in motivation for change: Lack of differences in the effects of two versus six sessions. Poster presented at the annual meeting of the Association for the Advancement of Behavior Therapy, New Orleans, LA.

10. Walker, N. R., Hunt, Y. M., Grothe, K., Parker, J. D., Burke, R. S., Dubbert, P. M., for the PATHS Research Group. (2005, November). Associations between tobacco use and alcohol moderation over time: Implications for clinical practice. Poster presented at the annual meeting of the Association for Behavioral and Cognitive Therapies, Washington DC.

11. Walker, N. R. (2009, February). Relationships among general coping, alcohol-specific coping, and alcohol use in a college student population. Poster presented at the annual meeting of the Texas Research Society on Alcoholism, San Antonio, TX.

12. Walker, N. R., Rosvall, T., Field, C., Eells, J., Adinoff, B. (2009, August). Outcomes and lessons learned: Disseminating contingency management and Motivational Interviewing in substance abuse treatment programs. Poster presented at the Early Career Poster Session sponsored by the National Institute on Drug Abuse, National Institute on Alcohol Abuse and Alcoholism, and APA Divisions 28 (Psychopharmacology and Drug Abuse) and 50 (Addictions) at the annual meeting of the American Psychological Association, Toronto, Canada. Accessible at http://ctndisseminationlibrary.org/display/392.htm.

13. Walker, N. R., Rosvall, T., Field, C., Eells, J., Adinoff, B. (2010, April). Outcomes and lessons learned: Disseminating contingency management and Motivational Interviewing in substance abuse treatment programs. Poster presented at the National Institute on Drug Abuse Blending Conference, Albuquerque, NM.

14. Shalvoy, A. M., Leachman, L. L., Walker, N. R., Minhajuddin, A., North, C. S., Rao, U., Xiao, H., Adinoff, B. (2010, June). Antisocial personality characteristics and alcohol use as a predictor of cortisol reactivity to a behavioral stressor. Poster presented at the annual Research Society on Alcoholism Conference, San Antonio, TX.

15. Leachman, L. L., Shalvoy, A. M., Fielding, S. K., Walker, N. R., Minhajuddin, A., North, C. S., Rao, U., Xiao, H., Adinoff, B. (2010, June). Relationship of self-reported childhood trauma to personality characteristics in alcohol-dependent men. Poster presented at the annual Research Society on Alcoholism Conference, San Antonio, TX.


16. Fielding, S. K., Shalvoy, A. M., Leachman, L. L., Minhajuddin, A., Walker, N. R., North, C. S., Rao, U., Xiao, H., Adinoff, B. (2010, June). Childhood trauma as a predictor of adult psychosocial stress in alcohol-dependent men. Poster presented at the annual Research Society on Alcoholism Conference, San Antonio, TX.

17. Walker, R., Carmody, T., Trivedi, M. H. (2011, June). Sociodemographic and clinical predictors of treatment retention and substance use outcomes. Poster presented at the annual meeting of the College on Problems of Drug Dependence, Hollywood, FL. Accessible at http://ctndisseminationlibrary.org/display/699.htm.

18. Braud, J., Harris, T. S., Devous, M. D., Spence, J. S., Briggs, R., Walker, R., Cullum, M., & Adinoff, B. (2012, March). Neural alterations during decision-making in cocaine-addicted subjects. Poster presented at the annual Metroplex Day for UT Arlington, UT Dallas, and UT Southwestern, Arlington, TX.

19. Forcehimes, A. A., Bogenschutz, M. P., Donovan, D. M., Crandall, C., Lindblad, R., Mandler, R., Perl, H. I., Walker, R. (2012, June). Implementing addiction treatment trials in medical settings in (NIDA’s) National Institute on Drug Abuse Clinical Trials Network. Poster presented at the annual meeting of the College on Problems of Drug Dependence, Palm Springs, CA.

20. Braud, J., Harris, T. S., Devous, M. D., Spence, J., Briggs, R., Walker, R., Cullum, M., Adinoff, B. (2012, June). Neural alterations during a decision-making task in cocaine-addicted subjects. Poster presented at the annual meeting of the Research Society on Alcoholism, Bryan, TX.

21. McHugh, M., Gu, H., Yang, Y., Braud, J., Devous, M., Briggs, R., Walker, N. R., Adinoff, B., Stein, E. (2012, December). Resting state network dynamics predict relapse in cocaine-dependent Individuals. Poster presented at the annual meeting of the American College on Neuropsychopharmacology, Hollywood, FL.

22. Gu H., McHugh M., Yang Y., Shope C., Braud J., Devous M., Briggs R., Walker N. R., Cullum M., Stein E., Adinoff B. (2012, December). Resting Regional Cerebral Blood Flow to Predict Relapse in Cocaine Dependent Individuals. Poster presented at the annual meeting of the American College on Neuropsychopharmacology, Hollywood, FL.

23. Northrup, T. F., Stotts, A. L., Warden, D., Walker, R., Greer, T., Rethorst, C., Thomas-Gordon, A., Mulpur, S., & Trivedi, M. (2013, March). An Ounce of Prevention: Rationale and Design for a Pre-Randomization Discussion to Strengthen Adherence and Retention. Poster presented at the annual Steering Committee meeting of NIDA’s National Drug Abuse Treatment Clinical Trials Network, Bethesda, MD.

24. Sanchez, K., Chartier, K. G., Greer, T. L., Walker, R., Carmody, T., Rethorst, C. D., Ring, K., Trivedi, M. H. (2013, March). Racial and ethnic differences among stimulant abusing/dependent inpatients in a residential treatment setting: A baseline analysis of the STRIDE cohort. Poster presented at the annual Steering Committee meeting of NIDA’s National Drug Abuse Treatment Clinical Trials Network, Bethesda, MD.


25. Stotts, A. L., Northrup, T. F., Potter, J. S., Marino, E. N., Walker, R., Trivedi, M., Weiss, R. D. (2013, June). Relations between craving and withdrawal and time to first opioid use among prescription opioid users initiating buprenorphine detoxification. Poster presented at the annual meeting of the College on Problems of Drug Dependence, San Diego, CA.

26. Sanchez, K., Chartier, K. G., Greer, T. L., Walker, R., Carmody, T., Rethorst, C. D., Ring, K., Trivedi, M. H. (2013, October). Racial and ethnic differences among stimulant abusing/dependent inpatients in a residential treatment setting: A baseline analysis of the STRIDE cohort. Poster presented at the annual National Hispanic Science Network Conference, Bethesda, MD.

27. Sanchez, K., Chartier, K. G., Greer, T. L., Walker, R., Carmody, T., Rethorst, C. D., Ring, K., Trivedi, M. H. (2014, June). Race and ethnicity differences among adults with stimulant use disorders in a residential treatment setting: A baseline analysis of the STRIDE cohort (update). Poster presented at the annual meeting of the College on Problems of Drug Dependence, San Juan, Puerto Rico. (Walker presented poster.)

28. Nielsen, D. A., Walker, R., Hamon, S. C., Hardin, M. H., Ling, W., Kosten, T. R. (2014, November). Cocaine addiction pharmacogenetics of buprenorphine therapy. Poster presented at the annual meeting of the Society for Neuroscience, Washington DC.

29. Oyama, M., Hillhouse, M., Thomas, C., Annon, J., Hasson, A., Mooney, L., Walker, R., Chang, L., Sparenborg, S., Ling, W. (2015, June). Using smartphone technology to monitor and increase dosing adherence. Poster presented at the annual meeting of the College on Problems of Drug Dependence, Phoenix, AZ.

30. Annon, J., Millhouse, M., Thomas, C., Mooney, L., Hasson, A., Walker, R., Chang, L., Sparenborg, S., Lindblad, R., VanVeldhuisen, P., Ling, W. (2015, June). A new study methodology: ADAPT, the short, staged trial. Poster presented at the annual meeting of the College on Problems of Drug Dependence, Phoenix, AZ.

31. Frimpong, J. A., Shiu, K., Feaster, D. J., Duan, R., Matheson, T., DeMicco, E., Sorenson, J., Walker, R., Drainoni, M., Gaskin, S., Stitzer, M.L., Mandler, R., Farber, E., del Rio, C., Metsch, L. R. (2015, June). Substance use disorders treatment history among hospitalized HIV-infect substance users in 11 US cities. Poster presented at the annual meeting of the College on Problems of Drug Dependence, Phoenix, AZ.

32. Hillhouse, M., Ang, A., Thomas, C., Nielsen, S., Walker, R., Potter, J., Brigham, G., Stout, S., Weimer, M., Winhusen, T. (2015, June). Opioid use severity and treatment outcome in cocaine-dependent participants with a history of opioid abuse/dependence. Poster presented at the annual meeting of the College on Problems of Drug Dependence, Phoenix, AZ.

33. Trombello, J. M., Carmody, T., Walker, R., Greer, T. L., Rethorst, C., Trivedi, M. H. (2015, June). Psychosocial relationship status and quality as predictors of exercise-based treatment adherence and substance use outcomes: Results from the STRIDE (CTN-0037) study. Poster presented at the annual meeting of the American Society of Clinical Psychopharmacology, Miami, FL.


34. Adinoff B., Spence J. S., Gu H., Rice J., Rubia K., Yang Y., Briggs R., Walker R., Stein E. A. (2015, December). Disrupted relationship of conscientiousness to BOLD activation during error monitoring and resting state functional connectivity. Poster presented at the annual meeting of the American College on Neuropsychopharmacology, Hollywood, FL.

35. Jester, B., Howe-Martin, L., Walker, R., de la Garza, N., Grannemann, B., Jha, M., Argenbright, K., & Trivedi, M. (2016, August). Evaluating a new standard-of-care psychopathology screening and treatment program in a community cancer clinic. Poster presented at the 124th annual Convention of the American Psychological Association, Denver, CO.

36. Howe-Martin, L., Lawrence, S.L., Jester, B., de la Garza, N., Benedetto, N., Mazour, T., Walker, R., Jha, M., Argenbright, K.E., & Trivedi, M.H. (2017, January). Implementing Mental Health Screening, Assessment, & Navigation Program in a Community-Based Survivorship Program. Poster presented at the Cancer Survivorship Symposium, San Diego, CA.

37. Howe-Martin, L., Jester, B., de la Garza, N., Walker, R., Jha, M., Argenbright, K., & Trivedi, M. (2017, February). MH-SCAN: Results from a pilot program to implement Mental Health Screening, Assessment, and Navigation in a community-based cancer center. Poster presented at the 2017 Annual Meeting of the American Psychosocial Oncology Society, Orlando, FL.

38. Liao, A., Walker, R., Carmody, T.J., Cooper, C., McInnis, M.G., Adams, P., Pizzagalli, D.A., Kurian, B.T., Fava, M., Parsey, R., McGrath, P.J., Weissman, M.M., Trivedi, M.H. (2017, April). Anxiety and anhedonia in major depressive disorder: The role of neuroticism, cognitive control, and reward learning. Poster presented at the Anxiety and Depression Association of America’s Anxiety and Depression annual conference, San Francisco, CA.

39. Howe-Martin, L., Jester, B., Hall, B.C., Walker, R., de la Garza, N, Benedetto, N., & Trivedi, M. (2017, December). Depression, anxiety, and suicidal Ideation in adolescent and young adult cancer survivors. Poster presented at the 2nd Annual Global AYA Cancer Congress, Atlanta, GA.

40. Walker, R., Kim, M., Sharma, G., Carmody, T., Sparenborg, S., dela Cruz, A. M., Ling, W., Trivedi, M. H. (2018, February). NIDA CTN Protocol 0068: Design of the Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder trial. Poster presented at the inaugural Celebration of Women in Science and Medicine at UT Southwestern, Dallas, TX.

41. Walker, R., Kim, M., Sharma, G., Carmody, T., Sparenborg, S., dela Cruz, A. M., Ling, W., Trivedi, M. H. (2018, June). NIDA CTN Protocol 0068: Design of the Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder trial. Poster presented at the annual meeting of the College on Problems of Drug Dependence, San Diego, CA.


42. dela Cruz, A.M., Mooney, L., Walker, R., Hillhouse, M., Trivedi, M.H., Ling, W. (2018, June). Rationale for combination XR-Naltrexone and bupropion XL for the treatment of methamphetamine use disorder. Poster presented at the annual meeting of the College on Problems of Drug Dependence, San Diego, CA.

43. Benedetto, N.N., Howe-Martin, L., de la Garza, N., Hayes, T., Walker, R. (2018, November). Implementation and Assessment of Two Different Depression and Anxiety Screening Guidelines in a Medical Setting. Poster presented at the 52nd Annual Association for Behavioral and Cognitive Therapies Convention, Washington D.C.

44. Liu, K., dela Cruz, A. M., Walker, R., Kim, M., Trivedi, M. H. (2019, January). Study Design of the Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT-2) Trial. Poster presented at the annual UT Southwestern Medical Student Research Forum.

45. Benedetto, N.N., Howe-Martin, L., de la Garza, N., Hayes, T., Walker, R. (2019, February). Implementation and Assessment of Two Different Depression and Anxiety Screening Guidelines in a Medical Setting. Poster presented at the second annual Celebration of Women in Science and Medicine at UT Southwestern, Dallas, TX.

Documents

ROBRINA WALKER PHD Curriculum vitae W… · Research Update in the Addictions University of Texas Southwestern Medical Center, Dallas, TX 2013 Conference Co-Director, Texas Addiction